“The global Mouth Ulcers Treatment market is anticipated to reach USD 1,550 Mn by 2030”, says Visiongain

16 October 2019
Pharma

Visiongain has launched a new pharma report ‘’Mouth Ulcers Treatment Market Report 2020-2030’’ by Formulation (Gel, Mouthwash, Ointment, Spray, Other Formulations), Drug Class (Analgesics & Corticosteroids, Antihistamine, Antimicrobial, Other Drug Classes), Indication (Aphthous Stomatitis, Oral Lichen Planus, Other Indications), and Geography.

The global Mouth Ulcers Treatment market is anticipated to grow at a lucrative CAGR of 4.1% and anticipated to reach USD 1,550 Million by 2030.

Mouth ulcers are painful sores that form on the mouth's soft tissue, including lips, cheek, tongue, and gums. Mouth ulcers may make eating, drinking, and brushing teeth difficult for some patients. Most of the ulcers in the mouth are benign, recurrent and get cleansed on their own within 1-2 weeks.

People, however, have a highly casual approach to mouth ulcers that can adversely affect market growth. There is a lack of awareness about the fact that they can lead to cancer if not treated during the early stages. Nevertheless, healthcare professionals are carrying out active initiatives and tests to raise awareness and avoid harmful effects caused by mouth ulcers. This trend is anticipated to boost the growth of global mouth ulcers market over the forecast period.

Also factors such as awareness of modern treatments, rising geriatric population, availability of rapid healing and easy to use products are anticipated to fuel the growth of the mouth ulcer treatment market.

Based on formulation, the global mouth ulcer treatment market is segmented into ointment, gel, mouthwash, spray, among other formulations. In the year 2018, gels held the majority of the global market share owing to rapid healing formulas, easy availability, and fast anti-inflammatory& anti-swelling properties. They also have anesthetic properties, which temporarily relieve mouth sores or ulcers from unbearable pain.

Asia Pacific region holds the majority of market share and is expected to experience the highest growth in terms of CAGR over the forecast period owing to supportive government initiatives and increasing awareness about oral hygiene. The region, on account of growing healthcare infrastructure and a large population base, is anticipated to open growth avenues for upcoming market players in the region.

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations and launching new products in order to strengthen their position in the global mouth ulcer treatment market. Companies are also increasing their R&D, distribution, and management facilities in order to expand their business and to hold a competitive edge in the market.

The comprehensive market report features companies such as 3M, Bristol Myers Squibb Company, Church & Dwight Co. Inc., Blistex Inc., Dr.Reddy’s Laboratories, Colgate- Palmolive Company, GlaxoSmithKline Plc., ECR Pharmaceuticals, Pfizer Inc., and Taro Pharmaceutical Industries Ltd. among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020–2030 for global markets such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Benelux, Russia, Poland, India, Japan, China, Australia, ASEAN, GCC, South Africa and North Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

Read

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

Read

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

Read

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever